Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and... Oncogene-induced senescence (OIS) is a critical tumor-suppressor mechanism, which prevents hyper-proliferation and transformation of cells. c-Myc promotes OIS through the transcriptional activation of p14ARF followed by p53 activation. Although the oncogene-mediated transcriptional regulation of p14ARF has been well addressed, the post-translational modification of p14ARF regulated by oncogenic stress has yet to be investigated. Here, we found that c-Myc increased p14ARF protein stability by inducing the transcription of ubiquitin-specific protease 10 (USP10). USP10, in turn, mediated the deubiquitination of p14ARF, preventing its proteasome-dependent degradation. USP10-null mouse embryonic fibroblasts and human primary cells depleted of USP10 bypassed c-Myc-induced senescence via the destabilization of p14ARF, and these cells displayed accelerated hyper-proliferation and transformation. Clinically the c-Myc-USP10-p14ARF axis was disrupted in non-small cell lung cancer patients, resulting in significantly worse overall survival. Our studies indicate that USP10 induced by c-Myc has a crucial role in OIS by maintaining the stability of key tumor suppressor p14ARF. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cell Death & Differentiation Springer Journals

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF

Download PDF
13 pages

Loading next page...
 
/lp/springer_journal/oncogene-induced-senescence-mediated-by-c-myc-requires-usp10-dependent-QJRCAKEmca
Publisher
Springer Journals
Copyright
Copyright © 2018 by ADMC Associazione Differenziamento e Morte Cellulare
Subject
Life Sciences; Life Sciences, general; Biochemistry, general; Cell Biology; Stem Cells; Apoptosis; Cell Cycle Analysis
ISSN
1350-9047
eISSN
1476-5403
DOI
10.1038/s41418-018-0072-0
Publisher site
See Article on Publisher Site

Abstract

Oncogene-induced senescence (OIS) is a critical tumor-suppressor mechanism, which prevents hyper-proliferation and transformation of cells. c-Myc promotes OIS through the transcriptional activation of p14ARF followed by p53 activation. Although the oncogene-mediated transcriptional regulation of p14ARF has been well addressed, the post-translational modification of p14ARF regulated by oncogenic stress has yet to be investigated. Here, we found that c-Myc increased p14ARF protein stability by inducing the transcription of ubiquitin-specific protease 10 (USP10). USP10, in turn, mediated the deubiquitination of p14ARF, preventing its proteasome-dependent degradation. USP10-null mouse embryonic fibroblasts and human primary cells depleted of USP10 bypassed c-Myc-induced senescence via the destabilization of p14ARF, and these cells displayed accelerated hyper-proliferation and transformation. Clinically the c-Myc-USP10-p14ARF axis was disrupted in non-small cell lung cancer patients, resulting in significantly worse overall survival. Our studies indicate that USP10 induced by c-Myc has a crucial role in OIS by maintaining the stability of key tumor suppressor p14ARF.

Journal

Cell Death & Differentiation – Springer Journals

Published: Feb 22, 2018

References

  • Senescence, apoptosis and therapy–cutting the lifelines of cancer
    Schmitt, CA
  • Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
    Serrano, M; Lin, AW; McCurrach, ME; Beach, D; Lowe, SW
  • Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
    Zindy, F; Eischen, CM; Randle, DH; Kamijo, T; Cleveland, JL; Sherr, CJ
  • Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all
    Gil, J; Peters, G
  • Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
    Lin, AW; Barradas, M; Stone, JC; Aelst, L; Serrano, M; Lowe, SW
  • ARF promotes MDM2 degradation and stabilizesp53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
    Zhang, Y; Xiong, Y; Yarbrough, WG
  • Association ofp19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
    Honda, R; Yasuda, H
  • Nucleolar Arf sequesters Mdm2 and activates p53
    Weber, JD; Taylor, LJ; Roussel, MF; Sherr, CJ; Bar-Sagi, D
  • Regulation of p53 stability by Mdm2
    Kubbutat, MH; Jones, SN; Vousden, KH
  • Mdm2 promotes the rapid degradation of p53
    Haupt, Y; Maya, R; Kazaz, A; Oren, M
  • p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress
    Eymin, B; Claverie, P; Salon, C; Leduc, C; Col, E; Brambilla, E
  • The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription
    Fatyol, K; Szalay, AA
  • Dynamics of ARF regulation that control senescence and cancer
    Ko, A; Han, SY; Song, J
  • Tumor spectrum in ARF-deficient mice
    Kamijo, T; Bodner, S; Kamp, E; Randle, DH; Sherr, CJ
  • Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging
    Matheu, A; Pantoja, C; Efeyan, A; Criado, LM; Martin-Caballero, J; Flores, JM
  • Alterations and hypermethylation of thep14(ARF) gene in gastric cancer
    Iida, S; Akiyama, Y; Nakajima, T; Ichikawa, W; Nihei, Z; Sugihara, K
  • 5′ cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer
    Hsu, HS; Wang, YC; Tseng, RC; Chang, JW; Chen, JT; Shih, CM
  • Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer
    Silva, J; Dominguez, G; Silva, JM; Garcia, JM; Gallego, I; Corbacho, C
  • Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer
    Lee, M; Sup Han, W; Kyoung Kim, O; Hee Sung, S; Sun Cho, M; Lee, SN
  • Distinct E2F-mediated transcriptional program regulates p14ARF gene expression
    Komori, H; Enomoto, M; Nakamura, M; Iwanaga, R; Ohtani, K
  • Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1
    Pollice, A; Nasti, V; Ronca, R; Vivo, M; Lo Iacono, M; Calogero, R
  • Transcriptional regulation of the human tumor suppressorp14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors
    Parisi, T; Pollice, A; Cristofano, A; Calabro, V; Mantia, G
  • Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses
    Chen, DL; Shan, J; Zhu, WG; Qin, J; Gu, W
  • Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF
    Ko, A; Shin, JY; Seo, J; Lee, KD; Lee, EW; Lee, MS
  • Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase
    Wang, XW; Zha, M; Zhao, XC; Jiang, P; Du, WJ; Tam, AYH
  • USP10 regulates p53 localization and stability by deubiquitinating p53
    Yuan, J; Luo, KT; Zhang, LZ; Cheville, JC; Lou, ZK
  • Vasopressin-inducible ubiquitin-specific protease 10 increases ENaC cell surface expression by deubiquitylating and stabilizing sorting nexin 3
    Boulkroun, S; Ruffieux-Daidie, D; Vitagliano, JJ; Poirot, O; Charles, RP; Lagnaz, D
  • The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells
    Bomberger, JM; Barnaby, RL; Stanton, BA
  • Deubiquitination and activation of AMPK by USP10
    Deng, M; Yang, X; Qin, B; Liu, TZ; Zhang, HX; Guo, W
  • USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation
    Draker, R; Sarcinella, E; Cheung, P
  • RNF168 and USP10 regulate topoisomerase II alpha function via opposing effects on its ubiquitylation
    Guturi, KKN; Bohgaki, M; Bohgaki, T; Srikumar, T; Ng, D; Kumareswaran, R
  • Ubiquitin-specific peptidase 10 (USP10) deubiquitinates and stabilizes MutS Homolog 2 (MSH2) to regulate cellular sensitivity to DNA damage
    Zhang, M; Hu, C; Tong, D; Xiang, SY; Williams, K; Bai, WL
  • The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53
    Pomerantz, J; Schreiber-Agus, N; Liegeois, NJ; Silverman, A; Alland, L; Chin, L
  • Transcriptional regulation and transformation by Myc proteins
    Adhikary, S; Eilers, M
  • A major functional difference between the mouse and human ARF tumor suppressor proteins
    Wadhwa, R; Sugihara, T; Hasan, MK; Taira, K; Reddel, RR; Kaul, SC
  • Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
    Jacobs, JJ; Scheijen, B; Voncken, JW; Kieboom, K; Berns, A; Lohuizen, M
  • MYC on the path to cancer
    Dang, CV
  • Amplification of the c-myc oncogene in non-small cell lung cancer
    Ozkara, HA; Ozkara, S; Topcu, S; Criss, WE
  • Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction
    Mitani, S; Kamata, H; Fujiwara, M; Aoki, N; Tango, T; Fukuchi, K
  • N-terminal polyubiquitination and degradation of the Arf tumor suppressor
    Kuo, ML; Besten, W; Bertwistle, D; Roussel, MF; Sherr, CJ
  • Generation of knockout mice using engineered nucleases
    Sung, YH; Jin, Y; Kim, S; Lee, HW